Texray, a Gothenburg-based startup with radiation protection solutions, has recently secured a €3.9 million (SEK 45 million) investment round led by Industrifonden and backed by private investors at Impilo, surpassing initial expectations. The company specializes in developing advanced radiation protection gear that addresses the heightened risks faced by healthcare professionals during x-ray-guided surgical procedures. Texray’s technology not only provides superior protection but also prioritizes the comfort of medical staff, aiming to revolutionize the field of Personal Protective Equipment (PPE). This investment infusion is set to accelerate Texray’s commercialization efforts, aiding in the broader market launch of their innovative products while furthering their mission to enhance occupational safety for healthcare professionals.
Texray specializes in developing advanced radiation protection solutions, addressing a critical problem healthcare professionals face. During x-ray-guided surgical procedures, these professionals routinely encounter some of the highest levels of radiation exposure in the field of medicine. Current radiation protection gear often leaves body parts such as the head and neck areas exposed, making medical staff potentially vulnerable to radiation-related health risks. Several comprehensive studies have underlined the elevated risk of malignancies and radiation-related diseases, such as cataracts, brain and neck tumors, among those exposed to radiation. The need to address this critical gap in radiation protection is urgent.
Texray’s groundbreaking technology not only offers the highest level of protection but also prioritizes the comfort and well-being of healthcare professionals dedicated to the safety and care of others. The company is revolutionizing the field of Personal Protective Equipment (PPE) with its patented technology platform. The platform has secured CE/FDA registrations and regulatory approvals across key global markets, including Europe, Japan, and the US.
Petra Apell, CEO of Texray, commented: “We are thrilled by the immense support we have received from investors who would like to join us on our journey when we aim to become one of the world’s leading companies in radiation protection. This investment will enable us to accelerate commercialization and to further our mission in advancing occupational safety for healthcare professionals with our cutting-edge technology.”
Texray currently offers two regulatory-approved products in its portfolio, used by over 1000 customers. This trust is further supported by strong endorsements from numerous key opinion leaders within the medical community. As Texray stands on the cusp of a broader market launch, the company’s dedication to revolutionizing radiation protection has never been more evident.
Tobias Elmquist, Senior Investment Director at Industrifonden, commented: “There is a growing awareness of the risks associated with radiation exposure among healthcare professionals, and Texray stands as the sole provider of a radiation protection textile that combines optimal shielding with a comfortable design, setting new industry standards for safety and comfort. Their technology represents a critical leap forward in safeguarding the lives of those who dedicate themselves to the well-being of others. We believe in the Texray mission and are excited to be part of their journey.”
Click to read more funding news.
Originally published on ArcticStartup : Original article